Storia in 2 fonti

Bayer Completes Acquisition of Perfuse Therapeutics

Raccontata da

healio.com

morningstar.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo2 mesi fa

Bayer Completes Acquisition of Perfuse Therapeutics

originale

healio.com2 mesi fa

Bayer acquires Perfuse Therapeutics

Bayer has acquired Perfuse Therapeutics, including the full rights to the PER-001 intravitreal implant, which is in development for glaucoma and diabetic retinopathy.

Leggi questa versione → originale

Timeline cronologica

mercoledì 17 giugno 2026·healio.com
Bayer acquires Perfuse Therapeutics
Bayer has acquired Perfuse Therapeutics, including the full rights to the PER-001 intravitreal implant, which is in development for glaucoma and diabetic retinopathy.
mercoledì 17 giugno 2026·morningstar.com
Bayer Completes Acquisition of Perfuse Therapeutics
Bayer Completes Acquisition of Perfuse Therapeutics